About Us Services Careers FAQ Contact Us 0
Home Bulk Chemicals Global Anti-Venom Market Demand, Industry Outlook to 2030
Anti-Venom Market

Anti-Venom Market Size, Share & Trends Analysis Report By Type (Polyvalent Heterologous Anti-venom, Monovalent Heterologous Anti-venom, Homologous Anti-venom, Small Molecule Anti-toxins), By Product Type (Snake Anti-venom, Scorpion Anti-venom, Spider Anti-venom, Others), By Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, Others), By End-User (Hospitals/clinics, Ambulatory Surgical Centers, Research Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRCH813DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Anti-Venom Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Polyvalent Heterologous Anti-venom
        1. By Value
      3. Monovalent Heterologous Anti-venom
        1. By Value
      4. Homologous Anti-venom
        1. By Value
      5. Small Molecule Anti-toxins
        1. By Value
    3. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Snake Anti-venom
        1. By Value
      3. Scorpion Anti-venom
        1. By Value
      4. Spider Anti-venom
        1. By Value
      5. Others
        1. By Value
    4. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Cytotoxic
        1. By Value
      3. Neurotoxic
        1. By Value
      4. Haemotoxic
        1. By Value
      5. Cardiotoxic
        1. By Value
      6. Myotoxic
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/clinics
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Research Institutes
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Polyvalent Heterologous Anti-venom
        1. By Value
      3. Monovalent Heterologous Anti-venom
        1. By Value
      4. Homologous Anti-venom
        1. By Value
      5. Small Molecule Anti-toxins
        1. By Value
    3. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Snake Anti-venom
        1. By Value
      3. Scorpion Anti-venom
        1. By Value
      4. Spider Anti-venom
        1. By Value
      5. Others
        1. By Value
    4. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Cytotoxic
        1. By Value
      3. Neurotoxic
        1. By Value
      4. Haemotoxic
        1. By Value
      5. Cardiotoxic
        1. By Value
      6. Myotoxic
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/clinics
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Research Institutes
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Polyvalent Heterologous Anti-venom
          1. By Value
        3. Monovalent Heterologous Anti-venom
          1. By Value
        4. Homologous Anti-venom
          1. By Value
        5. Small Molecule Anti-toxins
          1. By Value
      2. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Snake Anti-venom
          1. By Value
        3. Scorpion Anti-venom
          1. By Value
        4. Spider Anti-venom
          1. By Value
        5. Others
          1. By Value
      3. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Cytotoxic
          1. By Value
        3. Neurotoxic
          1. By Value
        4. Haemotoxic
          1. By Value
        5. Cardiotoxic
          1. By Value
        6. Myotoxic
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/clinics
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Research Institutes
          1. By Value
        5. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Polyvalent Heterologous Anti-venom
        1. By Value
      3. Monovalent Heterologous Anti-venom
        1. By Value
      4. Homologous Anti-venom
        1. By Value
      5. Small Molecule Anti-toxins
        1. By Value
    3. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Snake Anti-venom
        1. By Value
      3. Scorpion Anti-venom
        1. By Value
      4. Spider Anti-venom
        1. By Value
      5. Others
        1. By Value
    4. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Cytotoxic
        1. By Value
      3. Neurotoxic
        1. By Value
      4. Haemotoxic
        1. By Value
      5. Cardiotoxic
        1. By Value
      6. Myotoxic
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/clinics
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Research Institutes
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Polyvalent Heterologous Anti-venom
          1. By Value
        3. Monovalent Heterologous Anti-venom
          1. By Value
        4. Homologous Anti-venom
          1. By Value
        5. Small Molecule Anti-toxins
          1. By Value
      2. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Snake Anti-venom
          1. By Value
        3. Scorpion Anti-venom
          1. By Value
        4. Spider Anti-venom
          1. By Value
        5. Others
          1. By Value
      3. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Cytotoxic
          1. By Value
        3. Neurotoxic
          1. By Value
        4. Haemotoxic
          1. By Value
        5. Cardiotoxic
          1. By Value
        6. Myotoxic
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/clinics
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Research Institutes
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Polyvalent Heterologous Anti-venom
        1. By Value
      3. Monovalent Heterologous Anti-venom
        1. By Value
      4. Homologous Anti-venom
        1. By Value
      5. Small Molecule Anti-toxins
        1. By Value
    3. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Snake Anti-venom
        1. By Value
      3. Scorpion Anti-venom
        1. By Value
      4. Spider Anti-venom
        1. By Value
      5. Others
        1. By Value
    4. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Cytotoxic
        1. By Value
      3. Neurotoxic
        1. By Value
      4. Haemotoxic
        1. By Value
      5. Cardiotoxic
        1. By Value
      6. Myotoxic
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/clinics
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Research Institutes
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Polyvalent Heterologous Anti-venom
          1. By Value
        3. Monovalent Heterologous Anti-venom
          1. By Value
        4. Homologous Anti-venom
          1. By Value
        5. Small Molecule Anti-toxins
          1. By Value
      2. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Snake Anti-venom
          1. By Value
        3. Scorpion Anti-venom
          1. By Value
        4. Spider Anti-venom
          1. By Value
        5. Others
          1. By Value
      3. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Cytotoxic
          1. By Value
        3. Neurotoxic
          1. By Value
        4. Haemotoxic
          1. By Value
        5. Cardiotoxic
          1. By Value
        6. Myotoxic
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/clinics
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Research Institutes
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Polyvalent Heterologous Anti-venom
        1. By Value
      3. Monovalent Heterologous Anti-venom
        1. By Value
      4. Homologous Anti-venom
        1. By Value
      5. Small Molecule Anti-toxins
        1. By Value
    3. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Snake Anti-venom
        1. By Value
      3. Scorpion Anti-venom
        1. By Value
      4. Spider Anti-venom
        1. By Value
      5. Others
        1. By Value
    4. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Cytotoxic
        1. By Value
      3. Neurotoxic
        1. By Value
      4. Haemotoxic
        1. By Value
      5. Cardiotoxic
        1. By Value
      6. Myotoxic
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/clinics
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Research Institutes
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Polyvalent Heterologous Anti-venom
          1. By Value
        3. Monovalent Heterologous Anti-venom
          1. By Value
        4. Homologous Anti-venom
          1. By Value
        5. Small Molecule Anti-toxins
          1. By Value
      2. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Snake Anti-venom
          1. By Value
        3. Scorpion Anti-venom
          1. By Value
        4. Spider Anti-venom
          1. By Value
        5. Others
          1. By Value
      3. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Cytotoxic
          1. By Value
        3. Neurotoxic
          1. By Value
        4. Haemotoxic
          1. By Value
        5. Cardiotoxic
          1. By Value
        6. Myotoxic
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/clinics
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Research Institutes
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Polyvalent Heterologous Anti-venom
        1. By Value
      3. Monovalent Heterologous Anti-venom
        1. By Value
      4. Homologous Anti-venom
        1. By Value
      5. Small Molecule Anti-toxins
        1. By Value
    3. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Snake Anti-venom
        1. By Value
      3. Scorpion Anti-venom
        1. By Value
      4. Spider Anti-venom
        1. By Value
      5. Others
        1. By Value
    4. By Mode of Action
      1. Introduction
        1. Mode of Action By Value
      2. Cytotoxic
        1. By Value
      3. Neurotoxic
        1. By Value
      4. Haemotoxic
        1. By Value
      5. Cardiotoxic
        1. By Value
      6. Myotoxic
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals/clinics
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
      4. Research Institutes
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Polyvalent Heterologous Anti-venom
          1. By Value
        3. Monovalent Heterologous Anti-venom
          1. By Value
        4. Homologous Anti-venom
          1. By Value
        5. Small Molecule Anti-toxins
          1. By Value
      2. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Snake Anti-venom
          1. By Value
        3. Scorpion Anti-venom
          1. By Value
        4. Spider Anti-venom
          1. By Value
        5. Others
          1. By Value
      3. By Mode of Action
        1. Introduction
          1. Mode of Action By Value
        2. Cytotoxic
          1. By Value
        3. Neurotoxic
          1. By Value
        4. Haemotoxic
          1. By Value
        5. Cardiotoxic
          1. By Value
        6. Myotoxic
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals/clinics
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
        4. Research Institutes
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Anti-Venom Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Allison Medical Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hamilton Company
    3. Hill-Rom
    4. Hu-Friedy Mfg. Co.
    5. Medtronic Plc
    6. Novo Nordisk a/s
    7. Owen Mumford Ltd.
    8. Pfizer Inc.
    9. Bioclon Institute
    10. CSL limited
    11. BTG plc
    12. Merck and co.
    13. Sigma Aldrich
    14. Micropharm
    15. Boehringer-Ingelheim thermo fisher scientific
    16. Ultimed Inc.
    17. Ypsomed Holding AG.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Anti-VEGF Market Size & Trends The global anti-VEGF market size was worth USD 12.36 billion in 2021. It is expected to reach USD 13.54 billion by 2030, growing at a CAGR of 1.02% during the forecast period (2022–2030). Vascular Endothelial Growth F
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.